Changes between Version 50 and Version 51 of NIAID2024


Ignore:
Timestamp:
Feb 27, 2025, 1:59:19 PM (8 months ago)
Author:
Elaine Meng
Comment:

--

Legend:

Unmodified
Added
Removed
Modified

  • NIAID2024

    v50 v51  
    8989== 02/27/25 ==
    9090
    91 Eric, Zach, TomF, TomG, Elaine, Greg; Darrell, Meghan, Phil
     91Eric, Zach, TomF, TomG, Elaine, Greg; Darrell, Meghan, Phil, Kristen
     92
     93Mid-February visit to SF was canceled. This is the last meeting covered by our contract.
    9294
    9395Darrell: the end of an era. No plan for contract support through Guidehouse starting tomorrow. Other mechanism (supplement to R01) may still be viable.
    … …  
    9597TomF: we have pursued that and sent a document but not heard back. 
    9698
    97 Darrell: program officer is waiting for you to send a document, call it an extension. No need to mention NIAID specifically or to tailor the description to our interests. TomF: had not known that. Darrell: I hadn't conveyed it to you yet, was a recent development. Would be happy to take a look at your draft.  Should be before mid-April but best to get on it ASAP and send it before then. We're all trying to find a way to "yes", process goes through NIGMS even though the funds would come from NIAID.  Should be teed up for you. Level of support probably less than previous, but still significant.  Meghan: best to avoid mentioning covid, vaccines, and other potentially touchy subject areas.  Darrell: cryoEM is important, and AI advances. Should be same things as already in your R01 but saying that recent advances require more attention, time, and funding than provided by the existing R01. TomG: Boltz and other developments based on AlphaFold. Everybody: sounds ideal!
     99Darrell: program officer is waiting for you to send a document, call it an extension. No need to mention NIAID specifically or to tailor the description to our interests. TomF: had not known that. Darrell: I hadn't conveyed it to you yet, was a recent development. Would be happy to take a look at your draft.  Should be before mid-April but best to get on it ASAP and send it before then. We're all trying to find a way to "yes", process goes through NIGMS even though the funds would come from NIAID.  Should be teed up for you. Level of support probably less than previous, but still significant.  Meghan: best to avoid mentioning covid, vaccines, and other potentially touchy subject areas.  Darrell: cryoEM is important, and AI advances. Should be same things as already in your R01 but saying that recent advances require more attention, time, and funding than provided by the existing R01. TomG: Boltz and other developments based on !AlphaFold. Everybody: sounds ideal!
    98100
    99101Kristen: need some bullet-point documentation of the workflow in the 3D pipeline processing script. Elaine: punting that one to Eric, sorry.
    … …  
    101103Darrell: how would you like to set up meetings going forward?  What other meetings to you have?  TomF: our weekly group meeting Thurs 11am. TomG: our weekly ChimeraX programmer meeting Mon 3pm. Our usual approach is to have ad hoc meetings, drop-ins. Please feel free to email us anytime and we can set up Zoom meetings as needed.
    102104
    103 Meghan, Darrell: ChimeraX is now in our software center and we plan to have demonstrations, and maybe even encourage other institutes to take a similar approach.  Greg: We are thinking of changing how the license agreement works, may work better for this kind of setup in the future.
     105Meghan, Darrell: ChimeraX is now in our (NIAID-specific) software center and we plan to have demonstrations, and maybe even encourage other institutes to take a similar approach.  Greg: We are thinking of changing how the license agreement works, may work better for this kind of setup in the future.
     106
     107TomF: look at this new equipment, Sony spatial reality display.  Meghan: we looked at an Acer one before.  TomG: works pretty well with OpenXR, has eye tracking. [Darrell steps out, is not feeling well] Discussion of pricing of these types of displays. TomG: if you're interested, we're meeting with Acer on March 11.  Meghan: currently we as NIAID are not engaging with vendors, may be OK under Guidehouse auspices.  Phil: maybe things will change before then. TomG: they have a San Jose office, will be showing the display and leaving one with us.  They don't know much about biology, so one reason for the meeting is for us to tell them about the biological applications. You may want to weigh in on that. Meghan: send zoom invitations to the guidehouse email addresses for Phil and myself.
     108
     109More discussion of the experience of using this kind of display. More like VR than shutter-glasses stereo. TomG: I plan to write up a page on it, will send you the URL.
    104110
    105111[=#notes011625]